SBIR/STTR Research Award

Intravascular Imaging Catheter

Award identifier 87e7c038053a81f1d20814cda593518eeee2e189ab041c8ae5ab2da8438d467dAwarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$154,581

Program and phase

SBIR · Phase I

Award year

2001

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
OPTICAL BIOPSY TECHNOLOGIES, INC
Proposal award date
Not reported
Contract end date
Not reported
UEI
Not reported
Solicitation number
Not reported
Topic code
Not reported

Research abstract

Myocardial infarction is the leading causes of death. Biopsies have shown that atherosclerotic plaques may be the cause for many acute myocardial infarctions. In particular, vulnerable plaques are predisposed to rupture, which can result in clotting, reduction of blood flow to the heart, and sudden death. The identification of vulnerable plaque in vivo and their subsequent treatment could significantly reduce this cause for heart attacks. Various techniques for detection of intravascular plaques have been pursued including, angiograms, ultrasound imaging, optical coherence tomography imaging, magnetic resonance imaging, and thermal mapping. Optical coherence tomography has better resolution compared to other imaging techniques and is thus more capable of identifying critical features of vulnerable plaque. However, blood scatter light and can reduce the image penetration and contrast of optical coherent tomography. We will investigate a novel imaging technique that should more effectively reduce the noise caused by light scattered from blood thus allowing one to increase the probe strength increasing the contrast and depth of penetration. In addition, the proposed miniature microscope can have higher resolution than optical coherence tomography improving the identification of anatomic, biomechanical, and molecular features of vulnerable plaque. PROPOSED COMMERCIAL APPLICATIONS: Potential applications exist in detection of restenosis, vulnerable plaque, and thrombosis.

Technology keywords

Not reported

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.